The ProxyLite brand, founded in 2010 (Switzerland), from 2 sister brands and 2214 competing brands. The ProxyLite brand is owned by Addex Therapeutics, a company listed in Zurich. The International Securities Identification Number (ISIN) of Addex Therapeutics is CH0029850754. ProxyLite belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Addex Therapeutics
(ProxyLite)
over 5 years*
CHF 0.01